id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-023092-unjv71qv	Horzinek, Prof. Dr Marian C.	Feline leukaemia prophylaxis	2008-04-10		.txt	text/plain	2407	140	50	The humoral immune response against FeLV is directed mainly against the viral surface structure gp70/85 and against the so-called 'feline oncornavirus-associated membrane antigen' (FOCMA). The numerous experiments to develop an efficient vaccine against FeLV infection have recently shown their first success: in the U.S.A. a preparation is presently being marketed for use by the small animal practitioner. (1) cells (virus-producing, live or inactivated) (2) virus (live or inactivated) (3) split products (viral or cellular surface structures; gp7O/gp85, FOCMA) (4) synthetic antigens ( 5 ) products obtained by genetic engineering (antigens from pro-or eukaryotic Each of the above-mentioned strategies has been followed with varying success, cells after cloning of the respective viral genes) and the hope for the future is directed towards development of synthetic and genetically engineered vaccines. Vaccination against feline leukaemia virus using a cell membrane antigen system Feline leukemia virus envelope glycoprotein vaccine: preparation and evaluation of immunizing potency in guinea pig and cat	./cache/cord-023092-unjv71qv.txt	./txt/cord-023092-unjv71qv.txt